Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 579 of 1,261
  1. US 9908878

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  2. US 9909122

    Compositions and methods of nucleic acid-targeting nucleic acids

    Caribou Biosciences, Inc. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  3. CA 3034568

    PROCEDE DE PREVENTION D'ATTAQUES AIGUES D'OEDEME DE QUINCKE HEREDITAIRE ASSOCIEES A UNE DEFICIENCE EN INHIBITEUR DE C1 ESTERASE

    CSL BEHRING GMBH [DE] · Granted Mar 1, 2018 · Expires Feb 24, 2038

    granted
  4. US 9901546

    Orally disintegrable tablets

    Takeda Pharmaceutical Company Limited · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  5. US 9902690

    Ethoxylated surfactants

    The Board of Regents of the University of Oklahoma · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  6. US 9903855

    Assays for screening for or identifying an agent or molecule that can block or inhibit AVB3 integrin from forming a complex with KRAS

    The Regents of the University of California · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  7. US 9901638

    Composition and method for treating an autoimmune disease

    RedHill Biopharma Ltd. · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  8. US 9902781

    Antibodies for botulinum neurotoxins

    The Regents of the University of California · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  9. US 9901083

    Non-human animals having a humanized signal-regulatory protein gene

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  10. US 9901082

    Genetically modified non-human animals and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  11. US 9902955

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  12. US 9902780

    Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  13. US 9902769

    Treatment of dermatological pathologies

    XBIOTECH INC. · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  14. US 9902713

    Neuroprotective compounds and use thereof

    The Board of Regents of the University of Texas System · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  15. US 9902734

    Nicotinic acetylcholine receptor agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  16. US 9902712

    Nitrogenous heterocyclic derivatives and their application in drugs

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  17. US 9902703

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  18. US 9901648

    Stabilization of biomolecules using sugar polymers

    The Regents of the University of California · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  19. US 9901606

    Euglena lysate composition

    ALGAEON, INC. · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  20. US 9901619

    Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes

    The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  21. US 9901580

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    O.D. Ocular Discovery Ltd. · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  22. US 2018051034

    KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION

    4SC AG [DE] · Granted Feb 22, 2018 · Expires Feb 17, 2038

    granted
  23. EP 3283521

    ARZNEIMITTELKONJUGATE MIT ANTIKÖRPERN GEGEN MIT CLAUDIN 18.2

    GANYMED PHARMACEUTICALS GMBH [DE] · Granted Feb 21, 2018 · Expires Feb 16, 2038

    granted
  24. US 9895433

    Interferon-β production modulating listeria strains and methods for using same

    The Regents of the University of California · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.